MGT Capital Investments Inc.  

(Public, NYSEMKT:MGT)   Watch this stock  
Find more results for MGT Gaming, Inc
+0.005 (2.17%)
Feb 11 - Close
NYSEMKT real-time data - Disclaimer
Currency in USD
Range 0.21 - 0.25
52 week 0.15 - 1.00
Open 0.21
Vol / Avg. 173,027.00/231,596.00
Mkt cap 4.03M
P/E     -
Div/yield     -
EPS -0.32
Shares 17.90M
Beta 1.17
Inst. own 14%
Apr 13, 2016
Q4 2015 MGT Capital Investments Inc Earnings Release (Estimated) Add to calendar
Nov 17, 2015
Q3 2015 MGT Capital Investments Inc Earnings Release
More events from DailyFinance »    

Key stats and ratios

Q3 (Sep '15) 2014
Net profit margin -1054.44% -545.93%
Operating margin -618.89% -545.83%
EBITD margin - -466.38%
Return on average assets -43.03% -46.97%
Return on average equity -50.00% -54.29%
Employees 15 -
CDP Score - -


500 Mamaroneck Ave Ste 204
HARRISON, NY 10528-1600
United States - Map
+1-914-6307430 (Phone)
+1-302-6555049 (Fax)

Website links

External links

Analyst Estimates - MarketWatch
SEC Filings - EDGAR Online
Major Holders - MSN Money


MGT Capital Investments, Inc. (MGT), through its subsidiaries, is engaged in the business of acquiring, developing and monetizing assets in the online and mobile gaming space and social casino. The Company has four segments: Medicsight Software/Devices, Medicsight Services, Gaming and Intellectual Property. MGT's portfolio of assets in the online, mobile gaming and social casino gaming space includes, and Slot Champ. The Company's direct and indirect owned subsidiaries include MGT Gaming, Inc. (MGT Gaming), MGT Interactive LLC (MGT Interactive), Medicsight, Inc. (Medicsight), MGT Studios, Inc. (MGT Studios), M2P Americas, Inc., MGT Sports, Inc. (MGT Sports) and FanTD LLC, (FanTD).

Officers and directors

Robert B. Ladd President, Chief Executive Officer, Interim Treasurer, Interim Chief Financial Officer, Director
Age: 56
Bio & Compensation  - Reuters
H. Robert Holmes Independent Director
Age: 71
Bio & Compensation  - Reuters
Michael Onghai Independent Director
Age: 45
Bio & Compensation  - Reuters
Joshua N. Silverman Independent Director
Bio & Compensation  - Reuters